Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-6-25
pubmed:abstractText
In light of evidence that some complications of diabetes mellitus may be caused or exacerbated by oxidative damage, we investigated the effects of subacute treatment with the antioxidant quercetin on tissue antioxidant defense systems in streptozotocin-induced diabetic Sprague-Dawley rats (30 days after streptozotocin induction). Quercetin, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, was administered at a dose of 10mg/kg/day, ip for 14 days, after which liver, kidney, brain, and heart were assayed for degree of lipid peroxidation, reduced and oxidized glutathione content, and activities of the free-radical detoxifying enzymes catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase. Treatment of normal rats with quercetin increased serum AST and increased hepatic concentration of oxidized glutathione. All tissues from diabetic animals exhibited disturbances in antioxidant defense when compared with normal controls. Quercetin treatment of diabetic rats reversed only the diabetic effects on brain oxidized glutathione concentration and on hepatic glutathione peroxidase activity. By contrast, a 20% increase in hepatic lipid peroxidation, a 40% decline in hepatic glutathione concentration, an increase in renal (23%) and cardiac (40%) glutathione peroxidase activities, and a 65% increase in cardiac catalase activity reflect intensified diabetic effects after treatment with quercetin. These results call into question the ability of therapy with the antioxidant quercetin to reverse diabetic oxidative stress in an overall sense.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1095-6670
pubmed:author
pubmed:copyrightInfo
Copyright 2001 John Wiley & Sons, Inc. J Biochem Mol Toxicol 15:143-149, 2001
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
143-9
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:11424224-Animals, pubmed-meshheading:11424224-Antioxidants, pubmed-meshheading:11424224-Brain, pubmed-meshheading:11424224-Catalase, pubmed-meshheading:11424224-Diabetes Mellitus, Experimental, pubmed-meshheading:11424224-Glutathione, pubmed-meshheading:11424224-Glutathione Peroxidase, pubmed-meshheading:11424224-Glutathione Reductase, pubmed-meshheading:11424224-Kidney, pubmed-meshheading:11424224-Lipid Peroxidation, pubmed-meshheading:11424224-Liver, pubmed-meshheading:11424224-Male, pubmed-meshheading:11424224-Molecular Structure, pubmed-meshheading:11424224-Myocardium, pubmed-meshheading:11424224-Quercetin, pubmed-meshheading:11424224-Rats, pubmed-meshheading:11424224-Rats, Sprague-Dawley, pubmed-meshheading:11424224-Superoxide Dismutase, pubmed-meshheading:11424224-Thiobarbituric Acid Reactive Substances
pubmed:year
2001
pubmed:articleTitle
Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats.
pubmed:affiliation
Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405-7005, USA.
pubmed:publicationType
Journal Article